113 related articles for article (PubMed ID: 37422592)
21. Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis.
Liu ZL; Liu PP; Bi XW; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
Cancer Med; 2019 Mar; 8(3):874-881. PubMed ID: 30706675
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study.
Peckham-Gregory EC; Danysh HE; Brown AL; Eckstein O; Grimes A; Chakraborty R; Lubega J; McClain KL; Allen CE; Scheurer ME; Lupo PJ
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27896915
[TBL] [Abstract][Full Text] [Related]
23. Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.
Kasamon YL; Brodsky RA; Borowitz MJ; Ambinder RF; Crilley PA; Cho SY; Tsai HL; Smith BD; Gladstone DE; Carraway HE; Huff CA; Matsui WH; Bolaños-Meade J; Jones RJ; Swinnen LJ
Leuk Lymphoma; 2013 Mar; 54(3):483-90. PubMed ID: 22835045
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
Choi MK; Jun HJ; Lee SY; Kim KH; Lim DH; Kim K; Ko YH; Kim WS; Kim SJ
Ann Hematol; 2009 Nov; 88(11):1099-106. PubMed ID: 19288103
[TBL] [Abstract][Full Text] [Related]
25. Burkitt's Lymphoma of the Colon: A Case Report and Review of the Texas Cancer Registry.
Sato YZ; Hock RA; Garcia RL; Dihowm F
Cureus; 2022 Aug; 14(8):e27964. PubMed ID: 36120205
[TBL] [Abstract][Full Text] [Related]
26. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
Castillo JJ; Winer ES; Olszewski AJ
Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
[TBL] [Abstract][Full Text] [Related]
27. Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005.
Mbulaiteye SM; Anderson WF; Bhatia K; Rosenberg PS; Linet MS; Devesa SS
Int J Cancer; 2010 Apr; 126(7):1732-9. PubMed ID: 19810101
[TBL] [Abstract][Full Text] [Related]
28. Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
Bencomo-Alvarez AE; Gonzalez MA; Rubio AJ; Olivas IM; Lara JJ; Padilla O; Orazi A; Corral J; Philipovskiy A; Gaur S; Mulla ZD; Dwivedi AK; Eiring AM
Cancer; 2021 Apr; 127(7):1068-1079. PubMed ID: 33616915
[TBL] [Abstract][Full Text] [Related]
29. Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
Rodday AM; Hahn T; Kumar AJ; Lindenauer PK; Friedberg JW; Evens AM; Parsons SK
JAMA Netw Open; 2021 Oct; 4(10):e2128373. PubMed ID: 34673965
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
31. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
32. Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia.
Acharya S; Hsieh S; Shinohara ET; DeWees T; Frangoul H; Perkins SM
J Pediatr Hematol Oncol; 2016 Jul; 38(5):350-4. PubMed ID: 27177145
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia.
Della Rocca AM; Tonin FS; Fachi MM; Cobre AF; Ferreira VL; Leonart LP; Steffenello-Durigon G; Del Moral JAG; Lenzi L; Pontarolo R
Diseases; 2021 Jun; 9(2):. PubMed ID: 34203748
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
Kim HD; Cho H; Kim S; Lee K; Kang EH; Park JS; Park CS; Huh J; Ryu JS; Lee SW; Yoon DH; Kim SJ; Ko YH; Kim WS; Suh C
Cancer Res Treat; 2021 Jul; 53(3):847-856. PubMed ID: 33332932
[TBL] [Abstract][Full Text] [Related]
35. Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
Roschewski M; Dunleavy K; Abramson JS; Powell BL; Link BK; Patel P; Bierman PJ; Jagadeesh D; Mitsuyasu RT; Peace D; Watson PR; Hanna WT; Melani C; Lucas AN; Steinberg SM; Pittaluga S; Jaffe ES; Friedberg JW; Kahl BS; Little RF; Bartlett NL; Fanale MA; Noy A; Wilson WH
J Clin Oncol; 2020 Aug; 38(22):2519-2529. PubMed ID: 32453640
[TBL] [Abstract][Full Text] [Related]
36. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
[TBL] [Abstract][Full Text] [Related]
37. [Expression of p-AKT and p-mTOR in pediatric Burkitt lymphoma and their correlation with prognosis].
Man J; Chen L; Zhai XW; Ma YY; Wang HS; Qian XW; Feng JY; Zhao J; Cao P; Lu FJ
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):156-161. PubMed ID: 32074729
[No Abstract] [Full Text] [Related]
38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
39. Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma.
Graef CM; Gödel P; Falderbaum P; Balke-Want H; Simon F; Sieg N; Naendrup JH; Neumann MA; Gillessen S; Bröckelmann PJ; Eichenauer DA; Borchmann P; von Tresckow B; Heger JM
Eur J Haematol; 2022 May; 108(5):403-412. PubMed ID: 35090068
[TBL] [Abstract][Full Text] [Related]
40. Health Disparities of Coronavirus Disease 2019 in Texas, March-July 2020.
Xavier C; Rasu RS
South Med J; 2021 Oct; 114(10):649-656. PubMed ID: 34599344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]